Pharmaceutical Manufacturing and Packing Sourcer |
 |
|
|
|
| At the cutting edge of the latest industry developments, Samedan is adept at keeping the information you need at your fingertips. PMPS provides a unique platform of communication for the market across Europe, North America and the rest of the developed world. To find out what's hot in the world of pharmaceuticals, take a look below at the range of articles featured in this issue of PMPS |
 |
| |
|
|
| In her Editor's Letter, Patricia Lobo takes a look at the topics in this issue |
|
|
|
| Concerns surrounding formulating water-soluble drugs are contemplated by Dr Robert Harris at Penn Pharmaceutical Services Ltd, in Dissolving the NCE Issue |
|
|
| Jon Trembley of Air Products presents the innovative grinding technologies that are attempting to keep up with the market demand for fine particles, in Sizing it Up |
|
|
|
In Short-Term Gain Versus Long-Term Benefits, Karen Rossington at Shield Medicare exposes the myth that it is more efficient to manufacture your own alcohol in order to save money
|
|
|
| Six Sigma has been at the forefront of process improvement methods in the pharmaceutical industry. Simon Smith at Cambridge Consultants demonstrates his perspective, in Six Sigma: All Or Nothing? |
|
|
| In Validation: Do you Have the Skills? Modestino Graziano and Rob Beake at Bespak present a robust validation approach designed specifically for device manufacturers |
|
|
| The value of special fabrications is increasingly recognised by manufacturers. In Part of the Process, Dan Mathien at Swagelok Biopharm Services Company gives an insight into the requirements for adopting this method |
|
|
| Automation is proving to be a favoured avenue for driving down costs during the manufacturing process. James Cadogan at Parker Hannifin explains how, in Robot Wars |
|
|
|
| In the second part of our discussion with ATMI LifeSciences, PMPS talks to Rutger Vandiest about the company's latest developments, in Looking to the Future: One Company to Meet all your Disposable Contained Transfer Technology Needs |
|
|
In Dry Binders Used in Direct Compression, Angelika Maschke, Katherin Meyer-Bšhm and Karl Kolter at BASF investigate a popular way of manufacturing tablets
|
|
|
Felix Nink and Dr Torsten Schmidt-Bader at Bosch explore new technical solutions that are creating a contest with hard capsule filling, in Encapsulating a New Trend
|
|
|
|
In RABS: Injecting Change into Syringe Drug Delivery, Joerg Zimmerman of Vetter examines a unique method making headway in the aseptic filling of syringes
|
|
|
| The strict regulations which control water quality are a well-established feature in the pharmaceutical industry. In Designing a Solution for Water Quality Control, Alan Mortimer at ELGA LabWater illustrates how these increasingly far-reaching standards can be met through effective design |
|
|
|
|
Stability testing is an essential part of product development, yet improvements can still be made, contends Jane Sanderson of Brecon Pharmaceuticals, in A Stabilising Influence
|
|
|
In Small Sample, Big Impact, Dr Stephen Coulson at P2i Ltd explains how plasma enhancement provides an innovative way to functionalise products
|
|
|
The versatility of continuous inkjet printing is an attractive proposition for the pharmaceutical industry, asserts Charles Randon at Linx Printing Technologies
in CIJ Marks the Spot
|
|
|
In Foiling the Plans of Counterfeiters, Peter Tindale at Pillar Technologies shows how induction sealing is beneficial to the pharmaceutical industry as, amongst other uses, an effective anti-counterfeiting measure
|
|
|
In Speaking the Same Language, Craig Wylie and Tony Naderi at BearingPoint, outline how the issues attending the 'digital age' are particularly pertinent in the compliance of artwork and labelling in the pharmaceutical industry
|
|
|
|
Figures from the World Health Organization prove that, far from being defeated, anti-counterfeiting is a problem set to escalate. Rob Mitchell of CSMA uncovers a new method joining the battle against false medicines, in When The Drugs Don't Work
|
|
|
The far-reaching potential of biometric identification technology in user-authentication is well-acknowledged in the pharmaceutical industry, explains Peter Jones at Hitachi, in Taking it Personally
|
|
|
In Making Their Mark, PMPS talks to Nicole Golomb of Secutag about their latest developments 87 RFID has been widely championed as the way forward in providing visibility throughout the supply chain, argues Uwe Hennig at Intermec, Inc in Chain Gang
|
|
|
|
In Finding its Voice, Keith Wenzel, Adam Wood and Rick Peck at ClinPhone Inc, demonstrate the benefits of using IVRS to collect data from clinical studies
|
|
|
Dr Umakanta Sahoo and Dr Faiz Kermani at Chiltern present India as an attractive destination for the outsourcing of clinical trials, in A Fair Trial
|
|
|
Clinical trials are growing in scale and look to play a critical part in getting a drug to market as efficiently as possible. In Trial and Error, Jonathan Calderwood at Clinical Trial Services investigates the methods available to ensure that this process runs as smoothly as possible
|
|
|
Outsourcing is nothing new to the pharmaceutical industry. In Sourcing a More Efficient Route to Market, Paul Walsh at Bodycote Health Sciences presents the optimal method for choosing a partner
|
|
|
|
In Cold Chain Solutions, PMPS talks to Carel Van Oosterzee at Sensitech EMEA about the company's progression in cold chain visibility
|
|
|
Validation ensures that patients' expectations are met every time. In Practice Makes Perfect, Juan Vertelman at KLM Cargo demonstrates ways of optimising the supply chain in line with regulators' expectations
|
|
|
Dave Brennan at Special Cargo Standards, IATA, summarises the latest developments in the Infectious Substances Shipping Guidelines, in Updated IATA Guidelines Take Flight
|
|
|
The most relevant parts of the amended IATA Guidelines are exclusively laid out for our readers, in IATA: Are you Up to Date?
|
|
|
|
|
|
